News UK launches its 'Netflix-style' payment model for antibiotic... The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse decades of decline in the category.
Views & Analysis The US market in 2027: the evolving pricing and value landsc... An examination of the range of different trends and forces that are acting on the pharmaceutical sector.
News Takeda's narcolepsy programme gets back on track Takeda will move quickly ahead with regulatory filings for oveporexton as a treatment for narcolepsy after a pair of phase 3 wins.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face